Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Rs 621 crore bank...

    Rs 621 crore bank fraud: 3 pharma firm directors booked

    Written by Ruby Khatun Khatun Published On 2018-04-20T10:15:55+05:30  |  Updated On 20 April 2018 10:15 AM IST
    Rs 621 crore bank fraud: 3 pharma firm directors booked

    New Delhi: The CBI has registered a case against Surya Pharmaceuticals, its directors and officials of three companies based in Dubai and Patiala for allegedly cheating a consortium of five banks to the tune of Rs 621 crore, officials said on Tuesday.


    A case has been registered on charges of criminal conspiracy, cheating, forgery under the provisions of the Prevention of Corruption Act against Surya Pharmaceutical Ltd, its promoters and directors Rajeev Goel and Alka Goel.









    Pramod Aggarwal, director of Dubai-based Kobian Pvt Ltd and proprietor of Nimbus FZE, and Suhail Goel, director of Patiala-based Emsons Organic Ltd have also been booked.







    "Searches were conducted today at seven places -- two each in Delhi, Patiala and Chandigarh and one in Panchkula -- at the offices and residences of the accused which led to the recovery of certain documents," the CBI spokesperson said here.


    It is alleged that the accused defrauded the Punjab and Sindh Bank and four other banks of the consortium to the tune of about Rs 621 crore by diversion and siphoning off the loan through its sister concerns and not utilizing the credit for the purpose it was sanctioned i.e., manufacturing of pharmaceuticals, the spokesperson said.

    Alka Goelbank fraudbookedCBI)cheatingcriminal conspiracyDirectorsDubaiEmsons Organic LtdforgeryPatialaPharma FirmPramod AggarwalPrevention of Corruption ActPunjab BankRajeev GoelSindh BankSuhail GoelSurya Pharmaceuticals
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok